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levels on the cell surface (Rao and Craig, 1997; Liao et al., 1999; 
Crump et al., 2001). Also, in neurons of the visual cortex in dark-
reared animals, there is a change in the NR2A/NR2B ratio, which 
resets after only few hours of light exposure (Quinlan et al., 1999). 
Conversely, visual experience is needed for the maturational change 
of NR2A/NR2B ratio in the visual cortex, and this change can be 
slowed by blocking synaptic activity with tetrodotoxin (Carmignoto 
and Vicini, 1992; Quinlan et al., 1999; Chen and Bear, 2007). LTP of 
AMPAR EPSCs is accompanied by a  potentiation of NMDAR EPSCs 
(Bashir et al., 1991; Berretta et al., 1991; Aniksztejn and Ben-Ari, 
1995; Clark and Collingridge, 1995; Watt et al., 2004). Synaptic 
NMDAR levels can be regulated by   insertion of new   receptors 
into the membrane, but also by   lateral movement of extrasynap-
tic receptors into and out of the synapse (Tovar and Westbrook, 
2002; Zhao et al., 2008). NR2B-type receptors are highly mobile, 
whereas NR2A-type  receptors are fairly stable in the synapse (Groc 
et al., 2006). The regulation of lateral movement is also different for 
NR2A and NR2B subunits. The extracellular matrix protein Reelin 
for example decreases synaptic NR2B levels but has no inﬂ  uence 
on synaptic NR2A levels (Groc et al., 2007).
To study the regulation of NMDAR membrane insertion and its 
dependence on activity, we used a surface cleavage assay. A   similar 
approach has been used to investigate membrane insertion of 
adrenergic (Daunt et al., 1997) or AMPAR (Passafaro et al., 2001), 
which requires the presence of an extracellular receptor tag that can 
be cleaved off by thrombin. Our results show that NMDARs have a 
INTRODUCTION
Functional NMDA receptors (NMDAR) are heteromeric  assemblies 
of two NR1 and two NR2 subunits (Kutsuwada et  al., 1992; 
Hollmann, 1999). Of the four NR2 subunits, the NR2A and NR2B 
subunits are the most abundant ones in the forebrain. NR2B is 
highly expressed early in development, whereas NR2A   expression 
commences postnatally (Monyer et al., 1994). Receptors  containing 
NR2A or NR2B subunits differ substantially in their electrophysi-
ological   properties, with the NR2A subtype   characterized by 
faster deactivation and desensitization kinetics (Monyer et  al., 
1994). Triheteromeric NMDARs comprised of NR1, NR2A and 
NR2B receptors also exist, but their kinetic properties have not 
been determined due to lack of selective antagonists (Hatton 
and Paoletti, 2005). As of today, the role of NMDAR subtypes 
in   synaptic   plasticity, such as long-term potentiation (LTP) and 
depression (LTD), remains controversial (Liu et al., 2004; Massey 
et al., 2004; Berberich et al., 2005). Neurons can inﬂ  uence their 
NMDAR dependent reaction to glutamate by differential NR2A and 
NR2B expression. Synaptic AMPA receptor (AMPAR) expression 
is  regulated within minutes (Passafaro et al., 2001), commensurate 
with the ability of synapses to undergo LTP and LTD. Synaptic 
NMDARs on the other hand are thought to be rather stable in 
the membrane, at least in the adult brain (Wenthold et al., 2003). 
There is however increasing evidence that the level of membrane 
NMDARs is also regulated by activity. Blocking NMDAR activity in 
cultured neurons for   several days signiﬁ  cantly increases NMDAR 
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turnover time constant in the range of 10 h, and that NMDAR and 
AMPAR activation differentially regulate the number of NR2A-and 
NR2B-containing receptors in the   membrane. Moreover, our 
analysis of excitatory synaptic currents in CA1 neurons of acute 
hippocampal slices demonstrates that more NR2A- but not 
NR2B-containing receptors are functionally integrated into the 
synapse after NMDAR blockade.
MATERIALS AND METHODS
CONSTRUCTION OF TAGGED NMDAR
The coding sequence for enhanced green ﬂ  uorescent  protein (EGFP) 
and for the thrombin cleavage site (LVPRGS) were inserted by stand-
ard cloning techniques 3′ to the initial 66 bp of the NR2A coding 
sequence and to the initial 78 bp of the NR2B coding sequence (thus 
3′ of the predicted signal peptide sequences). To test for unspeciﬁ  c 
effects of thrombin, an EGFP-NR2B fusion   construct lacking the 
thrombin cleavage site was generated. The tagged NMDARs were 
expressed using the cytomegalovirus  promoter containing pRK as 
an expression vector.
PREPARATION AND TRANSFECTION OF CELL CULTURES
Primary hippocampal cell cultures were prepared as described 
(Brewer et  al., 1993). Dissociated hippocampal cells from E17 
C57Bl/6 mice were plated on poly-d-lysine (Sigma, St Louis, MO, 
USA) coated coverslips in 24-well culture dishes at a   density of 
3 × 105 cells per well. Cultures were incubated at 37°C in a humidi-
ﬁ  ed atmosphere of 5% CO2. Cells were fed by changing 1/2 medium 
to fresh Neurobasal medium every 4 days (Neurobasal medium, 
supplemented with 0.5 mM l-glutamine, 1% B27 Supplement and 
Penicillin/Streptomycin, all from Gibco, Karlsruhe, Germany). After 
5–7 days in vitro (DIV), growth of non-neuronal cells was halted by 
a 24-h exposure to 5-ﬂ  uor-2- deoxyuridine (5 µM uridine and 5 µM 
(+)-5-ﬂ  uor-2′-deoxyuridine, Sigma). Neurons were transfected at 
7 DIV using the Lipofectamin Transfection Kit.
HEK 293 cells were grown on glass coverslips coated with 
ﬁ  bronectin  (5 µg/cm2, Roche, Penzberg, Germany) in MEM 
(Gibco) supplemented with fetal calf serum, glutamine (Gibco) 
and Penicillin/Streptomycine (Gibco). 24 h after plating, cells were 
transfected using the calcium phosphate precipitation method. 
10 µM  d-2-amino-5-phosphonovaleric acid (D-APV, Tocris 
Bioscience, Bristol, UK) was added to prevent NMDA toxicity. 
Experiments were performed 48 h after transfection.
ELECTROPHYSIOLOGY
Recordings from HEK293 cells were performed 24–48  h after 
 transfection with (1) pRK-NR2A/pRK-NR1, (2) pRK-EGFP-NR2A/
pRK-NR1, (3) pRK-NR2B/pRK-NR1, (4) pRK-EGFP-NR2B/
pRK-NR1. pCS2dt-Tomato was always co-transfected for 
 identiﬁ  cation of transfected cells. Patch pipettes had a resistance 
of 3–5  MΩ when ﬁ  lled with the following solution (in mM): 
120 Cs-gluconate, 10 CsCl, 8 NaCl, 10 HEPES, 10 phosphocrea-
tine-Na, 0.3 Na3GTP, 2 MgATP, 0.2 EGTA (pH 7.3, adjusted with 
NaOH). Fast application of 100 µM NMDA (Sigma)/10 µM gly-
cine onto lifted HEK293 cells was performed as described (Jonas 
and Sakmann, 1992) using theta glass tubing mounted on a piezo 
translator (P-239.90, PI, Germany). Application pipettes were 
tested by perfusing solutions with different salt concentrations 
through the two barrels onto open patch pipettes and recording 
current changes with 500 ms moves of the application pipette. Only 
  application pipettes were used with current change 20–80% rise 
times below 100 µs and with a reasonable symmetrical on- and 
offset. The application solution contained (in mM): 135 NaCl, 5.4 
KCl, 1.8 CaCl2, 5 HEPES and 0.01 glycine (Sigma), adjusted to pH 
7.25 with NaOH. NMDAR-mediated currents were evoked with 
100 µM NMDA (Sigma).
Primary hippocampal cell cultures were recorded at DIV 17–20. 
Cells were continuously superfused with artiﬁ  cial  cerebrospinal ﬂ  uid 
(ACSF) (22–24°C) containing (in mM): 125 NaCl, 2.5 KCl, 2 CaCl2, 
1 MgCl2, 1.25 NaH2PO4, 25 NaHCO3, 25 glucose and 0.01 glycine, pH 
7.2 (maintained by continuous bubbling with carbogen). Whole-cell 
recordings were performed at room  temperature (22–25°C) using 
pipettes with resistance of 3–5 MΩ when ﬁ  lled with the following 
solution for the presynaptic cell (in mM): 105 K-gluconate, 30 KCl, 
10 HEPES, 10 phosphocreatine-Na, 0.3 Na3GTP, 4 MgATP, (pH 7.3, 
adjusted with KOH), and the   following solution for the postsyn-
aptic cell (in mM): 120 Cs-gluconate, 10 CsCl, 8 NaCl, 10 HEPES, 
10 phosphocreatine-Na, 0.3 Na3GTP, 2 MgATP, 0.2 EGTA (pH 7.3, 
adjusted with NaOH). Action  potentials (APs) were evoked by cur-
rent injection into a presynaptic cell (0.1 Hz), and EPSCs were 
recorded in a postsynaptic cell at a holding potential of +40 mV 
for NMDAR-mediated currents and −70 mV for AMPAR-mediated 
currents (for paired pulse ratio experiments). Averages of 30–100 
sweeps were analyzed. GABA-A currents were blocked with 10 µM 
SR95531 hydrobromide (gabazine, Biotrend, Wangen, Switzerland), 
AMPA currents (during NMDA current recording) with 10 µM 
6-cyano-7-  nitroquinoxaline-2,3-dione (CNQX, Tocris), NMDAR 
currents (during AMPA current recording) with 50 µM D-APV 
(50 µM, Tocris). Sensitivity for ifenprodil (10 µM, NR2B selective 
antagonist, Sigma) and NVP-AAM07 (50 nM, NVP, NR2A pre-
ferring antagonist, Novartis Pharmaceuticals, Basel, Switzerland) 
of NMDAR-mediated EPSCs was tested by measuring the change 
of the average amplitude of 30 sweeps (0.1 Hz) before and after 
incubation with ifenprodil or NVP. After washout of the   blockers, 
30 sweeps were recorded to rule out that amplitude changes 
were the result of unspeciﬁ  c rundown. Paired-pulse ratio (PPR) 
  experiments were performed by evoking APs in a presynaptic cell 
with inter-event intervals (IEI) of 25, 50, 100, 200, and 1000 ms 
and by   recording AMPAR-mediated EPSCs in a postsynaptic cell 
(averages of 25 EPSCs).
Two hundred ﬁ  fty micrometer transverse slices were prepared 
from brains of P14–P17 C57Bl/6 mice. Whole-cell recordings 
in   current- and voltage-clamp mode were performed at room 
 temperature  (22–25°C) using pipettes with resistance of 5 MΩ 
when ﬁ  lled with the following solution (in mM): 120 Cs-gluconate, 
10 CsCl, 8 NaCl, 10 Hepes, 10 phosphocreatine-Na, 0.3 Na3GTP, 
2 MgATP, 0.2 EGTA (pH 7.3, adjusted with NaOH). Slices were 
continuously superfused with ACSF (22–24°C) containing (in 
mM): 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4, 25 
NaHCO3, 25 glucose and 0.01 glycine, pH 7.2 (maintained by con-
tinuous   bubbling with carbogen). NMDA currents were evoked 
by extracellular activation of Schaffer collaterals and recorded in 
CA1 neurons that were held at a membrane potential of +40 mV. 
50–150 sweeps were averaged and NMDAR current amplitude 
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blocked with 10 µM SR95531 hydrobromide (gabazine, Biotrend, 
Wangen, Switzerland). An individual experiment comprised 
recordings from two pyramidal cells serving for normalization and 
  recordings from two to three pyramidal cells, after the slices had 
been incubated in ACSF for 8 h in the absence (control) or pres-
ence of D-APV (50 µM, Tocris). In control experiments, D-APV 
was added to the ACSF for 30 min after the 8-h incubation and 
then washed out prior to recording. All cells were in immediate 
proximity of each other. The position of the stimulation pipette 
and the stimulation strength remained constant during the whole 
experiment. The   constant position of the slice and stimulation 
pipette was   veriﬁ  ed by infrared-  differential interference contrast 
(DIC) images. For PPR experiments, AMPAR-mediated EPSCs 
were evoked by   extracellular activation of Schaffer collaterals 
(100 ms IEI) and recorded in CA1 neurons that were held at 
−70 mV (+50 µM D-APV and 10 µM gabazine to block NMDARs 
and GABA-A receptors, respectively). Neurons were visually iden-
tiﬁ  ed at an upright microscope (Axioskop FS2; Zeiss, Oberkochen, 
Germany) equipped with DIC and standard epiﬂ  uorescence.
NR2A/NR2B ratio was investigated by incubating slices for 8 h 
in ACSF in the absence (control) or presence of D-APV (50 µM). 
Control slices were incubated for 30 min in D-APV containing 
ACSF prior to the recording. NMDA currents were evoked by 
Schaffer collateral stimulation in CA1 pyramidal cells that were 
held at −70  mV. The extracellular solution was Mg2+ free and 
  contained (in mM): 125 NaCl, 25 NaHCO3, 1.25 NaH2PO4, 2.5 
KCl, 3 CaCl2, 25 glucose, 0.01 glycine, 0.005 bicuculline methio-
dide (Tocris, Bristol, UK), bubbled with 95% O2/5% CO2 (pH 7.4). 
AMPA currents were blocked with 10 µM 6-cyano-7-  nitroquinox
aline-2,3-dione (CNQX, Tocris). Ifenprodil sensitivity of synaptic 
NMDA currents in CA1 pyramidal cells was tested by measuring 
the change of the average amplitude of 50–150 sweeps before and 
after incubation with 10 µM ifenprodil. Stimulus delivery and data 
acquisition were performed using Pulse software (Heka Elektronik, 
Lambrecht, Germany). Signals were ﬁ  ltered at 5 kHz, sampled at 
10 kHz and analyzed off-line with IGOR Pro (Wavemetrics, Lake 
Oswego, OR, USA).
THROMBIN SURFACE CLEAVAGE ASSAY AND IMMUNOCYTOCHEMISTRY
The assay was as described (Hein et  al., 1994) with small 
 modiﬁ  cations. Bovine thrombin was applied at a   concentration 
of 0.1 U/ml (Roche, Mannheim, Germany), and its activity was 
blocked after 30  min with 0.4  mg/ml lepirudine (Reﬂ  udan®, 
Schering, Berlin, Germany). The following chemicals were used: 
10  µM MK801 (NMDA antagonist, Sigma), 100  µM D-APV 
(NMDA antagonist, Tocris), 10 µM ifenprodil, 50 nM NVP, 10 µM 
NMDA plus 10  µM glycine, 10  µM CNQX, 2  µM nimodipine 
  (voltage gated calcium channel blocker, Sigma), and 1 µM tet-
rodotoxin (TTX, Tocris). For membrane staining of NMDARs, 
rabbit anti-EGFP antibody (1:10000, Molecular Probes, Eugene 
Oregon) in   phosphate buffer saline (PBS) with 5% normal goat 
serum and 4% bovine serum albumin were added onto the non-
permeabilized non-ﬁ  xed cells for 1 h at 4°C. Cells were cooled to 
4°C for 10 min before adding the anti-EGFP antibody to prevent 
receptor-antibody internalization. After several washing steps, cells 
were ﬁ  xed with 4% paraformaldehyde and 3% sucrose in PBS 
for 8 min, and secondary anti-rabbit antibody (Alexa Fluor 555 
goat anti   rabbit IgG (H + L), 1:1000, Molecular Probes) in PBS 
was added for 24 h at 4°C. Cell identiﬁ  cation based on staining 
of surface bound   receptors was not possible directly after cleav-
age of the extracellular tag and   difﬁ  cult 2–24 h thereafter. Thus, 
transfected cells were identiﬁ  ed based on the   positivity for intra-
cellularly localized tagged  receptors. The intrinsic intensitiy of the 
EGFP-tag was often too low to  unequivocally  identify positive cells. 
Hence, we performed an anti-EGFP immunocytochemistry with a 
green secondary antibody after permeabilization of the cells with 
0.2% Triton in PBS for 5 min at room temperature. The subse-
quent steps were similar to those used for the staining of surface 
bound receptors, with the   exception that a different secondary 
antibody was used (Alexa Fluor 488 goat anti rabbit IgG (H + L), 
1:1000, Molecular Probes). HEK293 cells were stained in a similar 
way. For quantiﬁ  cation of total cell staining intensity Z-stacks of 
four images per cell were acquired with a Leica DM IRE2 confo-
cal microscope using a 40× lens (Leica, Wetzlar, Germany). For 
quantiﬁ  cation of NMDAR  clusters 3–5 dendrites of each cell were 
chosen for analysis (30–180 µm for each dendrite).
Metamorph software (Universal Imaging Cooperation, 
West Chester, Pennsylvania) was used to quantify the intensity 
of the EGFP staining. A maximum projection of each z-stack 
was   generated, background subtraction was performed, and all 
images were similarly thresholded. The total signal-intensity 
of the thresholded area was quantiﬁ  ed for each cell. For cluster 
analysis we measured the area, integrated intensity and number 
of clusters. Total intensity of clusters per 100 µm dendrite was 
calculated as the product of integrated cluster intensity and clus-
ter number/100 µm dendrite. Measurements were analyzed using 
Microsoft Excel. To calculate the time course of the subunit reap-
pearance, data were ﬁ  tted with a mono-exponential association 
equation using IGOR Pro.
STATISTICS
Data are presented as mean ± SEM unless noted otherwise. Statistical 
analyses were performed using SigmaStat 3.11. Differences between 
groups were examined using Student’s t-test, one-way ANOVA with 
Boferroni t-test for multiple comparisons, Mann–Whitney rank 
sum test, or Kruskall–Wallis one-way analysis of variance with 
a Dunn’s posttest for multiple comparisons. p values <0.05 were 
  considered statistically signiﬁ  cant.
RESULTS
EGFP-TAGGED RECEPTORS ARE ELECTROPHYSIOLOGICALLY 
FUNCTIONAL AND ARE TRANSPORTED TO THE CELL MEMBRANE
To quantify the turnover of NMDAR subunits, we N-terminally 
tagged NR2A and NR2B subunits with EGFP and a cleavage site 
for the extracellular protease thrombin. EGFP might change 
the   correct folding of the receptor or interfere with the binding 
of agonists and thus alter the receptor function. To   investigate 
if the tagged receptors are targeted to the cell membrane, 
HEK293 cells were co-transfected with NR1 and EGFP-NR2A or 
EGFP-NR2B, and cell surface-bound receptors were visualized by 
 immunostaining with EGFP antibodies under non-permeabilizing 
conditions (Figure 1A). As previously shown (Fukaya et al., 2003), 
co- expression of the NR1 subunit was necessary for NR2 insertion 
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currents in   hippocampal primary cell cultures (Figure 2A). There 
was no change in the peak amplitude of NMDAR-mediated cur-
rents (measured at +40 mV holding potential) when compared to 
postsynaptic control cells (peak ctr: 15 pA [7–42], n = 28, EGFP-
NR2A: 19 pA [10–36], n = 17, EGFP-NR2B: 21 pA [11–53], n = 18, 
median ± interquartile range (IQR), >0.05, Kruskall–Wallis one-
way analysis of variance, Figure 2C). Since NR2A- and NR2B-con-
taining NMDARs differ  considerably in their deactivation kinetics 
(Monyer et al., 1994), we also quantiﬁ  ed the weighted tau (τw) of 
NMDAR-mediated EPSCs (Figure 2B). NMDAR-mediated currents 
decayed signiﬁ  cantly faster in cells expressing EGFP-NR2A (τw ctr: 
288 ± 61 ms,  n = 31,  EGFP-NR2A:  129 ± 20 ms,  n = 12,  EGFP-
NR2B: 290 ± 35 ms, n = 10, <0.05 ctr vs. EGFP-NR2A, one-way 
ANOVA, Figure 2C), indicating that over-expression of tagged 
subunits changed the composition of synaptic NMDARs without 
changing their absolute number. Similar results for changes in EPSC 
kinetics but not amplitudes were reported for synaptic NMDAR-
mediated currents in  cerebellar granule cells over- expressing NR2A 
and NR2B subunits (Prybylowski et al., 2002).
TURNOVER OF NR2A AND NR2B SUBUNITS
NR2A-containing NMDARs are developmentally regulated in vivo 
(Monyer et al., 1994) and in vitro (Li et al., 1998). To investigate 
the turnover rate of NR2A- and NR2B-containing receptors in 
the cell membrane, experiments were performed at DIV 17–18, a 
time point at which both NMDAR subtypes are expressed (Li et al., 
1998). The extracellular EGFP-tag was cleaved off enzymatically by a 
30-min thrombin treatment. After incubating the neurons for 2, 4, 6, 
8 and 24 h following thrombin treatment, newly inserted receptors 
were visualized immunocytochemically under non-permeabilizing 
We tested whether tagged receptors were functional by   recording 
currents during fast application of NMDA (100  µM, 500  ms) 
  application onto transfected HEK293 cells (Figure 1B). Currents 
mediated by tagged and untagged receptors were similar in ampli-
tude (NR1/NR2A wt: 152  ± 56 pA,  n = 16;  NR1/EGFP-NR2A: 
160 ± 37 pA, n = 12; NR1/NR2B wt: 73 ± 25 pA, n = 22; NR1/EGFP-
NR2B: 52 ± 14 pA, n = 11, p > 0.05), 20–80% rise time (NR1/NR2A 
wt: 6.1  ± 0.8 ms,  n = 13;  NR1/EGFP-NR2A:  5.8 ± 0.5 ms,  n = 12; 
NR1/NR2B wt: 11.7 ± 1.7 ms, n = 12; NR1/EGFP-NR2B: 10.5 ± 1 ms, 
n = 10, p > 0.05), deactivation time constant after the 500 ms NMDA 
pulse (τw: NR1/NR2A wt: 23.2 ± 6.9 ms, n = 10; NR1/EGFP-NR2A: 
22.4 ± 4.7 ms, n = 12; NR1/NR2B wt: 43.7 ± 3.4 ms, n = 13; NR1/
EGFP-NR2B: 45.8 ± 4.1 ms, n = 8, p > 0.05), and steady state cur-
rent at the end of the 500 ms NMDA pulse (as a percentage of peak 
current: NR1/NR2A wt: 67 ± 4%, n = 13; NR1/EGFP-NR2A: 67 ± 4%, 
n = 12; NR1/NR2B wt: 74 ± 4%, n = 15; NR1/EGFP-NR2B: 79 ± 3%, 
n = 9, p > 0.05). Deactivation   kinetics were much faster than those 
of glutamate-evoked currents (Monyer et  al., 1994) or synaptic 
NMDAR-mediated   currents (see below), as expected for the lower 
afﬁ  nity agonist NMDA (Patneau and Mayer, 1990). Normal properties 
of tagged NR2A and NR2B subunits (although without the thrombin 
cleavage site) have been previously reported (Luo et al., 2002).
Importantly, the tagged receptors were targeted to the cell 
 membrane in HEK293 cells and in transfected neurons of hippoc-
ampal primary cell cultures (Figures 1C,E). Higher  magniﬁ  cation 
revealed that the tagged receptors in neurons were localized in 
spine-like structures (Figures 1D,F). We investigated by paired 
recordings of a presynaptic non-transfected cell and a postsynaptic 
EGFP-NR2A or EGFP-NR2B expressing cell if over-expression of 
EGFP-NR2A and EGFP-NR2B changes synaptic NMDAR-mediated 
EGFP-NR2A A
C DF
40 pA
20 pA
B
20 pA 20 pA
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EGFP-NR2B
EGFP-NR2A
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FIGURE 1 | EGFP-tagged NMDARs are transported to the cell membrane and 
are functional. (A) HEK293 cells were co-transfected with NR1 and EGFP-tagged 
NR2A or NR2B. The surface staining of extracellular EGFP (red) under non-
permeabilizing conditions shows tagged NMDA receptors transported to the cell 
membrane. Scale bar: 5 µm. (B) Application of 100 µM NMDA and 10 µM glycine 
(500 ms) induced an inward current in HEK293 cells co-transfected with NR1 and 
EGFP-NR2A or EGFP-NR2B. These currents could be blocked with the NMDAR 
antagonist APV and were similar to the currents in HEK293 cells co-transfected 
with NR1 and wildtype NR2A or NR2B. (C,D) Primary hippocampal cultures were 
transfected with vectors for EGFP-NR2A (C/D) or EGFP-NR2B (E/F). Surface 
staining of extracellular EGFP (red) under non-permeabilizing conditions shows 
that tagged NMDARs are transported to the cell membrane also in neurons. (C/E) 
Higher magniﬁ  cation shows that EGFP-NR2A and EGFP-NR2B receptors can be 
observed in spine-like structures (D/F). Scale bar: 8 µm.Frontiers in Molecular Neuroscience  www.frontiersin.org  October 2009  | Volume 2  |  Article 19  |  5
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conditions (anti-EGFP antibody for 1 h at 4°C before ﬁ  xing the 
cells with paraformaldehyde), using as a secondary   antibody Alexa 
Fluor 555 goat anti rabbit IgG. We observed that vigorous washing 
of the cells to remove the thrombin caused a strong reduction of 
receptor insertion during the ﬁ  rst hours post washing. Vigorous 
washing is stressful for neurons and can cause cell death and sub-
sequent over-activation of NMDAR by glutamate (unpublished 
  observations), which might explain the reduced insertion of new 
receptors. Thus, rather than removing thrombin by washing, we 
added lepirudine, a small peptide that binds thrombin at the active 
site and blocks protease activity (Nowak, 2002). Combined thrombin 
and lepirudine treatment for 8 h per se had no effect, since the inten-
sity of EGFP-NMDAR surface staining was not different from that 
of untreated cells. In contrast, near-complete absence of staining was 
observed after 30 min thrombin treatment (Figure 3E), demonstrat-
ing that the thrombin cleavage site engineered into the NR2 subunits 
was functional and that no antibody internalization occurred during 
surface staining of tagged receptors. Insertion of new EGFP-tagged 
NR2A and NR2B receptors into the cell membrane was investigated 
over a time period of 24 h. After this time, the staining intensity of 
cell membrane-inserted receptors was 75 ± 9% and 42 ± 4% of the 
control staining for tagged NR2A- and NR2B-containing receptors 
respectively. The mono-exponential ﬁ  t of the data shows that the 
time constants of reappearance were virtually the same for NR2A 
and NR2B receptors with 9.2 and 9.7 h, respectively. Interestingly, 
the maximum of the monoexponential ﬁ  t was 81% for NR2A- and 
46% for NR2B-type receptors. This might indicate that NMDARs 
whose EGFP-tags had been removed by thrombin and had been 
internalized, became subsequently reinserted into the cell membrane 
(Figures 3A–D). To test for unspeciﬁ  c   inﬂ  uence of thrombin on 
NMDAR  expression in the cell membrane, we  generated EGFP-NR2B 
fusion   constructs lacking the thrombin cleavage site. Transfected 
cultures were treated for 30 min with thrombin,  followed by appli-
cation of lepirudine. The intensity of EGFP surface staining 24 h 
later was not  signiﬁ  cantly different in these cultures when compared 
to cultures   simultaneously treated with thrombin and lepirudine 
(ctr: 100 ± 8%, n = 40, thrombin: 94 ± 6%, n = 80, p > 0.05, ±SEM) 
(Figure 3F),   indicating that 30 min thrombin-treatment does not 
affect the expression of NMDAR in the cell membrane. Thus, the 
differential levels of reinsertion indicate that NR2B-type NMDARs 
undergo less   degradation after internalization than NR2A-types.
INFLUENCE OF GLUTAMATE RECEPTOR AGONISTS AND ANTAGONISTS 
ON NMDAR SURFACE EXPRESSION
Treatment of neuronal cultures with NMDA antagonists for  several 
days signiﬁ  cantly increases synaptic NR1 receptors clusters (Rao 
and Craig, 1997). We investigated if blocking of NMDARs leads 
to up-regulation of NR2A- and NR2B-containing receptors, 
and whether such up-regulation is mediated by the blockade 
of either NR2A- or NR2B-type receptors or both. Treatment of 
  transfected neurons with the NMDA antagonist MK-801 or APV 
for 8 h increased the surface expression of NR2A-type receptors 
by approximately twofold (242 ± 22% and 177 ± 20% for MK801 
and APV respectively, n = 46 and 25 cells, p < 0.001) (Figure 4A). 
A   signiﬁ  cant increase of membrane-bound NR2A-type recep-
tors to 150% of baseline level could be observed already after 4 h 
of treatment with MK801 (152  ± 17%,  n = 30  cells,  p < 0.001, 
data not shown). Blocking for 8 h NR2A- or NR2B-containing 
  receptors with 50 nM NVP or 10 µM ifenprodil, respectively, did 
not change the amount of cell membrane-bound NR2A-type 
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FIGURE 2 | Changes of NMDAR-mediated currents observed in cells 
expressing tagged receptors. (A) Infrared DIC image of three cultured 
hippocampal cells of which two were connected. Current injection into the 
lower cell evoked an AP (red), and an NMDAR-mediated EPSC (black, +40 mV) 
could be recorded in the upper cell. The ﬂ  uorescence image below shows that 
the upper cell expressed EGFP-NR2B. Scale bar = 50 µm. (B) Example traces 
of NMDAR-mediated currents in control (ctr) cells and cells expressing 
EGFP-NR2A and EGFP-NR2B (C) Expression of tagged receptors did not 
change the peak amplitude of NMDAR-mediated EPSCs median ± IQR) but 
expression of EGFP-NR2A signiﬁ  cantly decreased the weighted tau (τw) of the 
EPSC deactivation (mean ± SEM). Control = ctr, EGFP-NR2A = 2A, 
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FIGURE 3 | Turnover of NR2A and NR2B receptors in the cell membrane 
occurs in the range of several hours. (A) In control condition (ctr), thrombin 
and lepirudine were added simultaneously. Surface staining of the EGFP-tag 
under non-permeabilizing conditions shows strong staining of cell membrane-
bound receptors, conﬁ  rming the potency of lepirudine in blocking the thrombin 
activity. Thrombin treatment for 30 min effectively cleaved off the extracellular 
EGFP , as revealed by loss of EGFP immunoreactivity (0 h). With the insertion of 
new receptors into the cell membrane, EGFP immunoreactivity increased 
between 2 and 24 h (2–24 h). Scale bars: 40 µm. (B,C) After 24 h the signal was 
75% and 42% of the control signal for NR2A- (B) and NR2B-type (C) receptors 
respectively. In (D) the mono-exponential ﬁ  ts for the NR2A (red, left y-axis) and 
NR2B (black, right y-axis) data are scaled to the extrapolated maximal intensity, 
showing that turnover time constants were similar for both NMDAR subtypes. 
(E) Thrombin (Thr) effectively cleaves the EGFP-tag (EGFP-NR2A), and this 
cleavage can be blocked with lepirudine (Lep) for many hours. The extracellular 
EGFP was visualized with an EGFP antibody and a Cy3-coupled secondary 
antibody under non-permeabilizing conditions. (F) To test for unspeciﬁ  c 
inﬂ  uence of thrombin on the surface expression of NMDARs, cells were 
transfected with an EGFP-NR2B control construct lacking the thrombin 
cleavage site and were treated with thrombin (30 min). After 24 h, the intensity 
of the EGFP surface stain was not different from that of cells simultaneously 
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 receptors (NVP:  109  ± 15%, 31 cells; ifenprodil: 106 ± 16%, 32 cells, 
p > 0.05) (Figure 4A). Thus, the activation of either  subtype is suf-
ﬁ  cient to keep NR2A-containing receptors in the cell   membrane 
at baseline levels.
If NMDAR blockade can change the cell surface receptor 
  expression, NMDAR activation could have the opposite effect. 
However, after 8-h treatment with 10  µM NMDA (+10 µM 
 glycine),  no  signiﬁ  cant change was observed in the surface 
expression of NR2A (105 ± 11%, n = 28 cells, p > 0.05). Hence, 
decreased but not increased NMDAR activitation regulates the 
NMDAR levels (Figure 4A). Surprisingly, in contrast to the 
strong increase of NR2A-type receptors during MK-801 and 
APV treatment, no signiﬁ  cant change of NR2B-type recep-
tor surface levels could be observed (MK-801: 105  ± 15% 
n = 27, p > 0.05; APV: 87.3 ± 5% n = 75, p > 0.05) (Figure 4B). 
Furthermore, the use of NVP, ifenprodil and NMDA failed to 
change the surface staining intensity of NR2B (NVP: 80 ± 4%, 
156 cells; ifenprodil: 100 ± 9%, 51 cells; NMDA: 100 ± 10% 25 
cells, p > 0.05) (Figure 4B). Thus, blocking NMDAR activity dif-
ferentially regulates the expression of the two NMDAR subtypes 
in the cell membrane.
Moreover, blocking AMPARs, but not voltage-gated Ca2+-channels 
(VGCC), signiﬁ   cantly increased the expression of NR2A-type 
receptors (10 µM CNQX: 207 ± 27%, 40 cells; 2 µM nimodipine: 
134 ± 10%, 96 cells, p < 0.05). No signiﬁ  cant change in the amount of 
NR2B-containing receptors could be observed (CNQX: 112 ± 17%, 
45 cells; nimodipine: 107 ± 12%, 32 cells, p > 0.05) (Figures 4A,B). 
Thus, the selective regulation of NR2A-type NMDARs occurs by 
activity blockade of NMDARs and AMPARs.
NMDAR AND AMPAR ACTIVITY REGULATES THE MEMBRANE 
INSERTION OF NEW RECEPTORS
Different scenarios can account for the above-described effect on 
NMDAR surface expression: altered receptor levels could result 
from increased insertion of new receptors, decreased receptor 
 internalization, or both. Thus, following cleavage of the EGFP-tag of 
the membrane-bound receptors, the insertion of new receptors was 
investigated under the same blocking or activating conditions used 
before. Data were normalized to the values obtained from cultures 
simultaneously treated with thrombin and lepirudine. MK-801 for 
8 h caused a strong increase in new NR2A-type receptor insertion 
(control: 46 ± 4%, 128 cells; MK-801: 194 ± 22%, 30 cells, p < 0.001) 
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FIGURE 4 | Activation of NMDARs and AMPARs regulates the number of 
NR2A- but not NR2B-type receptors in the cell membrane. Blocking 
NMDARs with MK-801 (MK), APV and CNQX for 8 h increased the surface 
staining for the tagged NR2A- (A) but not NR2B-subtype (B). (C,D) The increase 
in membrane-bound NR2A-type receptors can be explained by increased 
insertion of new receptors during the treatment with MK-801 and CNQX 
(C). No change in the insertion of NR2B-type receptors could be observed 
(D). The subtype preferring blockers NVP and ifenprodil (Ifen), NMDA, and the 
blocking of VGCC with nimodipine (Nimo) had no effect on the levels of NR2A-
type (A) and NR2B-type receptors (B) in the cell membrane, and these agents 
failed to affect the insertion of new receptors into the cell membrane (C,D). The 
intensity of the membrane stain in these experiments was normalized to the 
intensity of the membrane stain of cultures simultaneously treated with 
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(Figure 4C). The augmented insertion of new NR2A-containing 
receptors from 46% (control) to 194% (MK-801) is the most par-
simonious explanation for the increase in total NR2A-type surface 
receptors from 100% (control) to 242% (MK-801), although we can-
not rule out that NMDAR block also changes receptor internalization. 
No signiﬁ  cant increase in NR2A-type receptor insertion could be seen 
when the NR2A- or NR2B-type receptors were blocked singly (NVP: 
67 ± 7%, 89 cells; ifenprodil: 60 ± 6%, 91 cells, p > 0.05) (Figure 4C). 
Consistent with the increase in the total number of receptors after 
blocking AMPAR with CNQX, the same treatment signiﬁ  cantly 
increased the insertion of new NR2A-type receptors (101 ± 13%, 
n = 37 cells, p < 0.001; Figure 4C). No signiﬁ  cant increase in the inser-
tion of NR2A-type receptors was observed when blocking VGCC or 
activating the cells with 10 µM NMDA (nimodipine: 58 ± 7%, 84 cells; 
NMDA: 40 ± 13%, 24 cells, p > 0.05) (Figure 4C).
In contrast to the highly regulated insertion of NR2A-type 
  receptors, there was no altered insertion of NR2B-type   receptors 
upon activity change. Neither the blocking of NMDARs   (control: 
22 ±  2%, 82 cells; MK-801: 30  ±  4%, 43 cells; NVP: 22  ± 5%, 
42 cells;  ifenprodil:  25 ±  2%, 27 cells, p >  0.05) nor the use 
of CNQX, nimodipine or NMDA (CNQX: 27  ±  3%, 35 cells; 
nimodipine: 30 ± 5%, 34 cells; NMDA: 23 ± 4%, 28 cells, p > 0.05) 
(Figure 4D), changed the insertion of new NR2B-containing 
 receptors   signiﬁ  cantly. This ﬁ  nding is consistent with a lack of 
inﬂ  uence of activity on the total amount of membrane-inserted 
NR2B-type receptors.
Quantiﬁ  cation of changes in NMDAR number was performed 
in all the above experiments by visualizing NMDAR on the cell 
surface and measuring the total intensity of the EGFP staining for 
each cell. Hence, a change in the intensity reﬂ  ects a change in the 
total number of NMDAR on the surface. Since it is unclear if this 
change in cell surface NMDARs includes a change in synaptic or 
extrasynaptic NMDARs (or both), we performed an analysis of 
NMDAR clusters that should mainly reﬂ  ect synaptic NMDARs. 
There was a trend to an increase in the integrated intensity (NR2A 
ctr: 3457 ± 778 units, 15 cells; 8 h APV: 4590 ± 565 units, 14 cells, 
p > 0.05) and area (NR2A ctr: 0.21 ± 0.04 µm2, 15 cells; 8 h APV: 
0.26 ± 0.03 µm2, 14 cells, p > 0.05) of NR2A cluster staining and a 
signiﬁ  cant increase in the number of NR2A clusters per 100 µM 
dendrite (NR2A ctr: 108 ± 7, 15 cells; 8 h APV: 154 ± 8, 14 cells, 
p < 0.001) in cells that had been treated for 8 h with APV when 
compared to control cells. There was also a signiﬁ  cant increase in 
the total staining intensity per 100 µm dendrite (number of clusters 
per 100 µM × mean integrated intensity of clusters) in cells treated 
with APV for 8 h (NR2A ctr: 383,701 ± 99,006 units, 15 cells; 8 h 
APV: 677,682 ± 78,165 units, 14 cells, p < 0.05), consistent with the 
increase of the total staining intensity of the entire cell (Figure 5A). In 
contrast to the observed changes in NR2A  clusters, there was no dif-
ference in integrated intensity/cluster (NR2B ctr: 4481 ± 920 units, 
10 cells; 8 h APV: 5061 ± 807 units, 12 cells, p > 0.05) area/cluster 
(NR2B ctr: 0.26 ± 0.04 µm2, 10 cells; 8 h APV: 0.26 ± 0.04 µm2, 12 
cells, p > 0.05) cluster number/100 µM (NR2B ctr: 115 ± 6, 10 cells; 
8 h APV: 105 ± 6, 12 cells, p > 0.05) and total staining intensity/
100 µM dendrite (NR2B ctr: 538,538 ± 129,024 units, 10 cells; 8 h 
APV: 532,486 ± 78,878 units, 12 cells, p < 0.05) for NR2B clusters 
in control and 8 h APV treated cells. In   summary, cluster analysis 
showed that APV treatment   inﬂ  uenced the   localization of NR2A 
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FIGURE 5 | APV treatment increases number and total staining intensity 
of NR2A but not NR2B clusters. Sample images show EGFP-NR2A (A) and 
EGFP-NR2B (B) clusters on dendrites of control and APV (8 h) treated cells. 
Clusters were visualized under non-permeabilizing conditions with an anti-
EGFP antibody (red). Intracellular EGFP-NR2A and EGFP-NR2B subunits can 
be seen in green. Scale bar = 5 µm. (A) Quantiﬁ  cation of clusters shows that 
APV treatment leads to an increase in number and total staining intensity of 
NR2A clusters (per 100 µm dendrite). There was a trend for an increase in size 
and integrated intensity of NR2A clusters on cells treated with APV. (B) No 
difference in any of these parameters could be observed for NR2B clusters, 
when comparing control and APV-treated cells (mean ± SEM).
subunits without changing the distribution of NR2B   subunits 
and indicated that the number of synaptic NR2A subunits might 
increase (Figure 5B).
NMDA RECEPTOR ACTIVATION REGULATES SYNAPTIC NMDA EPSCS 
IN PRIMARY HIPPOCAMPAL CELL CULTURES
The immunocytochemical experiments on cell cultures had shown 
that the number of NR2A- receptors increases on the cell surface, 
and cluster analysis indicated that number of synaptic NR2A 
 subunits increases during NMDAR blockade. Since not all NMDAR 
clusters on the cell surface reﬂ  ect synaptic NMDARs, we sought Frontiers in Molecular Neuroscience  www.frontiersin.org  October 2009  | Volume 2  |  Article 19  |  9
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to   corroborate these data by electrophysiological   measurements 
and investigated if newly inserted receptors contribute to synap-
tic currents. We thus recorded NMDAR-mediated currents (at a 
holding potential of +40 mV) of connected cell pairs in primary 
hippocampal cell cultures. 8-h treatments with APV signiﬁ  cantly 
increased the peak amplitude of NMDAR-mediated EPSCs 
 compared to control (30 min APV) cells (EPSC peak control: 17 pA 
[6–33], 30 pairs, EPSC peak after 8 h APV: 31 pA [20–59], 28 pairs, 
median ± interquartile range (IQR), p = 0.002, Mann–Whitney rank 
sum test),  indicating that the  synaptic NMDAR number increased 
(Figure 6A). Consistent with an increase in the   synaptic NR2A/
NR2B ratio we observed after 8 h of APV   treatment a decrease 
in the EPSC decay (τw), when compared to the EPSC decay τw in 
control cells (τw control: 234 ms [181–267], 31 pairs, τw after 8 h 
APV: 153 ms [134–193], 24 pairs, median ± IQR, p = 0.008, Mann–
Whitney rank sum test, Figure 6A). A change in the NR2A/NR2B 
ratio should also alter the NMDAR current sensitivity to the NR2B 
selective and the NR2A preferring NMDAR blockers ifenprodil and 
NVP. Ifenprodil (10 µM) decreased by more than 60% the peak 
amplitude of NMDAR-mediated currents in paired recordings. The 
reduction in ifenprodil-mediated peak amplitude was signiﬁ  cantly 
smaller in cell pairs treated for 8 h with APV (% remaining current 
with ifenprodil, control: 34 ± 5%, 7 pairs; after 8 h APV: 51 ± 3%, 
8 pairs, p > 0.01, Student’s t-test, Figure 6B). NMDAR-  mediated 
peak current amplitudes   recovered nearly   completely after ifen-
prodil   washout (% current after   washout, control: 89  ± 13%, 
7 pairs; after 8 h APV: 94 ± 8%, 8 pairs, p > 0.05, Student’s t-test, 
Figure 6B). In contrast to the decrease in ifenprodil sensitivity there 
was an increase in the   sensitivity for the NR2A-preferring blocker 
NVP (50 nM) after treatment with APV for 8 h (% remaining cur-
rent with NVP, control: 66 ± 5%, 6 pairs; after 8 h APV: 46 ± 6%, 6 
pairs, p > 0.05, Student’s t-test, Figure 6C). The NMDAR-mediated 
currents recovered also nearly completely after NVP-washout (% 
current after washout, control: 97 ± 6%, 6 pairs; after 8 h APV: 
91 ± 7%, 6 pairs, p > 0.05, Student’s t-test, Figure 6C).
A change in current amplitude can reﬂ   ect an increase in 
the number of synaptic receptors or an increase in the release 
  probability. To test for changes in presynaptic function, we 
  measured the PPR of AMPAR-mediated EPSCs (20, 50, 100, 200, 
and 1000 ms IEI) of connected pairs in hippocampal cell   cultures. 
There was no   difference in the PPR between pairs in control 
cultures (30  min APV) and APV (8  h) treated cultures (PPR 
  control, 25 ms IEI: 0.96 ± 0.06, 50 ms IEI: 0.89 ± 0.05, 100 ms IEI: 
0.88 ± 0.03, 200 ms IEI: 0.87 ± 0.03, 1000 ms IEI: 0.91 ± 0.1, n = 16; 
after 8 h APV, 25 ms IEI: 0.98 ± 0.12, 50 ms IEI: 0.8 ± 0.06, 100 ms 
IEI: 0.81 ± 0.05, 200 ms IEI: 0.84 ± 0.06, 1000 ms IEI: 0.96 ± 0.04, 
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FIGURE 6 | APV treatment increases synaptic NMDAR-mediated EPSCs in 
cultured cells. (A) Paired recordings were performed in primary hippocampal 
cultures. APs (red) were evoked in a presynaptic cell, and NMDAR-mediated 
EPSCs (black) were recorded in a postsynaptic cell at a holding potential of 
+40 mV. Cultures were treated either for 30 min with APV (control) or for 8 h 
with APV before recording. 8 h-APV increased the peak amplitude of NMDAR-
mediated EPSCs and decreased the τw of the EPSC deactivation (median ± IQR). 
(B) Example traces of NMDAR-mediated currents without and with ifenprodil 
and after washout of the NR2B-selective blocker. The quantiﬁ  cation shows the 
decrease in ifenprodil sensitivity in cells treated for 8 h with APV compared to 
control cells (mean ± SEM). (C) Example traces of NMDAR-mediated currents 
without and with NVP and after washout of the NR2A-preferring blocker. The 
quantiﬁ  cation shows the increase in NVP sensitivity in cells treated for 8 h with 
APV compared to control cells (mean ± SEM). (D) 8 h of APV treatment did not 
change the PPR of AMPAR-mediated EPSCS. EPSCs were evoked with IEI of 
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n = 13; p > 0.05, Student’s t-test, Figure 6D). Hence, a change in 
the release   probability does not account for the difference in the 
current amplitude in control and APV-treated slices.
These experiments indeed show that the treatment of   cultures 
with APV increases the amount of NR2A-type NMDAR on 
the cell surface of cultured cells and also increases the number 
of NMDAR in the synapse, primarily by increasing synaptic 
NR2A-type   receptors, consistent with the immunocytochemi-
cal experiments. Moreover, these experiments, performed with 
non-transfected cells, indicate that the results obtained with trans-
fected cells are unlikely to reﬂ  ect an unphysiological reaction of 
cells over-  expressing tagged NMDARs.
NMDA RECEPTOR ACTIVATION REGULATES SYNAPTIC NMDA EPSCs 
IN CA1 NEURONS OF ACUTE HIPPOCAMPAL SLICES
The cell culture experiments showed that the amount of 
NR2A-containing membrane-bound receptors increases by 
NMDAR blockade and that these receptors are integrated into 
the synapse. To rule out that these changes reﬂ  ect an artifact of 
the primary cell culture system, we performed additional electro-
physiological experiments in acute hippocampal slices, which are 
physiologically more relevant than cultured neurons. NMDA cur-
rents were evoked in CA1 pyramidal cells (membrane potential 
of +40 mV) by Schaffer collateral/commissural ﬁ  ber stimulation. 
NMDA EPSCs of two control cells were recorded without changing 
position of the stimulation pipette or the stimulation strength and 
were compared to the current amplitudes of 1–3 cells that were 
adjacent to the control cells, after incubating the slices for 8 h in 
extracellular solution in the presence or absence of APV. In con-
trol experiments, NMDA EPSCs did not change signiﬁ  cantly after 
8 h (before incubation: 100 ± 9.2%, 8 cells; after 8 h: 92 ± 12.2%, 
14 cells, p > 0.05). In contrast, there was a signiﬁ  cant increase of 
the NMDA EPSCs after 8-h incubation in APV (before incuba-
tion: 100 ± 10.6%, 8 cells; after 8 h + APV: 188 ± 30.1%, 10 cells, 
p < 0.05) (Figure 7A). Similar to our experiments in cell cultures 
we tested for changes in presynaptic function that could explain 
a change in NMDAR-mediated current amplitudes. We measured 
the PPR of AMPAR-mediated EPSCs (100 ms interval). There was 
no signiﬁ  cant change in the PPR after 8 h in control solution (PPR 
before incubation: 1.49 ± 0.09, 7 cells; after 8 h + APV: 1.34 ± 0.05, 
14 cells, p > 0.05) and in APV-treated slices (before incubation: 
1.46 ± 0.05, 10 cells; after 8 h + APV: 1.34 ± 0.07, 10 cells, p > 0.05, 
Figure 7B). Hence, a change in the release probability does not 
account for the difference in the current amplitude in control and 
APV-treated slices.
To investigate whether the NR2A/NR2B ratio changes during 
APV treatment also in slices, we tested the ifenprodil sensitivity of 
synaptic NMDAR-mediated EPSCs in CA1 neurons during Schaffer 
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FIGURE 7 | APV treatment increases synaptic NMDAR-mediated EPSCs in 
CA1 neurons of acute hippocampal slices. (A) Synaptic EPSCs were evoked 
in hippocampal slices by stimulation of Schaffer collateral/commissural 
ﬁ  bers. EPSCs were recorded in adjacent pyramidal cells at a holding 
potential of +40 mV. Control slices (condition a) were incubated in ACSF 
for 7 .5 h, followed by 30 min ACSF + APV (APV) and an APV-free ACSF-step for 
30 min prior to recording. This treatment did not change the EPSC amplitude. 
In contrast, 8 h of APV treatment (condition b) induced an increase in the 
EPSC amplitude. EPSC amplitudes recorded in two adjacent cells at the 
beginning of the experiments were used for normalization (mean ± SEM). Also 
shown are infrared DIC images to control for the invariant position of the 
stimulation pipette throughout the experiment in stratum radiatum (sr) and to 
guarantee recordings from neighboring cells at the beginning and end of the 
experiments in stratum pyramidale (sp). (B) There was no change in PPR of 
AMPAR-mediated EPSCs (recorded at −70 mV) during condition a or condition 
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collateral/commissural ﬁ  ber stimulation (Mg2+-free extracellular 
solution, holding potential of −70 mV). The ifenprodil block of 
NMDAR EPSCs was signiﬁ  cantly smaller in slices treated with APV 
for 8 h than in control slices (% remaining current with ifenprodil; 
ctr: 60.7% (51.9–78), 24 cells; after 8 APV: 84.4% (67.2–93.2) 22 cells, 
median ± IQR, p < 0.005) (Figure 8). The EPSC decay was signiﬁ  -
cantly faster in neurons of slices treated for 8 h with APV than in those 
kept for 8 h in control solution [τw control: 104.1 ms (83.7–123.3), 
24 cells; τw + APV: 83.6 ms (77.2–110.3), 22 cells, median ± IQR, 
p < 0.05], consistent with increased synaptic NR2A/NR2B ratios 
(Figure 8). Thus, prolonged NMDAR blockade results in the  selective 
upregulation of synaptic NR2A-containing NMDARs.
DISCUSSION
The NR2A and NR2B subunits mark the principal NMDAR 
 subtypes in the forebrain. These differ in developmental expression 
(the NR2B-type receptor is present already early in development, 
whereas expression of the NR2A subtype starts postnatally) and 
electrophysiological properties (Monyer et al., 1994). Differences 
in the role of NR2A- and NR2B-type receptors in LTP and LTD 
induction have been proposed (Tang et al., 1999; Liu et al., 2004; 
Massey et al., 2004; Berberich et al., 2005; Weitlauf et al., 2005; 
Bartlett et al., 2007; Morishita et al., 2007), but conclusive  evidence 
has not yet been obtained. Indeed, NMDAR expression changes, 
and particularly the differential synaptic regulation of the two 
NMDAR subtypes, may be crucial for the subsequent  induction of 
distinct downstream signaling cascades. Such differential  regulation 
may well be important for modifying cellular responses upon 
NMDAR activation.
To investigate whether and how the insertion of NMDAR  subtypes 
in the cell membrane is regulated, we ﬁ  rst measured turnover rates. 
In contrast to a fast turnover rate of AMPARs with time constants 
around 30 min (Passafaro et al., 2001), NMDAR insertion into the 
cell membrane occurred much slower. Indeed, the intensity of newly 
inserted tagged NR2A- and NR2B-type receptor staining reached 
75% and 42% of control values, respectively, 24 h after cleaving off 
the EGFP-tag. The mono-exponential ﬁ  t of the data shows that the 
turnover time constants are virtually the same, with 9.2 and 9.7 h 
respectively for NR2A- and NR2B-type receptors. The maximum of 
the monoexponential ﬁ  t was not 100%, but 81% and 46% respec-
tively for the two subtypes. This can be expected if internalized recep-
tors, whose tag was cleaved off, are recycled and reinserted into the 
cell membrane. In fact, it was shown that after internalization, NR2B-
containing receptors are not only targeted to endosomes for degrada-
tion but also reinserted into the cell membrane (Scott et al., 2004). 
Our data indicate that the recycling of NR2B-type receptors exceeds 
that of NR2A-containing receptors. These results are consistent with 
previous ﬁ  ndings, indicating that approximately 50% of NR2B-type 
receptors were sorted to recycling endosomes after internalization, 
whereas the NR2A subtype was preferentially   targeted to late endo-
somes (Lavezzari et al., 2004). It is not clear though, whether the 
EGFP-tag itself has an inﬂ  uence on the turnover, targeting to endo-
somes and recycling of NMDARs. It is possible that the tag changes 
the proportion of receptors that are either degraded or recycled after 
internalization. The tag could thus inﬂ  uence the maximal surface 
staining intensity observed after un-tagging NMDARs. It is simi-
larly unclear if endogenous receptors can form with tagged receptors 
heteromeric assemblies that might show a different turnover rate 
when compared with pure endogenous receptors.
Related studies have addressed several issues pertinent to our 
results. Thus, studies on biotinylated receptors in cultured neu-
rons showed that the turnover-rate of NMDAR is developmentally 
regulated. In young cultures (DIV 4), >50% of the NR1 subunit 
was internalized after 5 min (Washbourne et al., 2004). Also, the 
percentage of cortical NR2B-type receptors that were endocytosed 
within 30 min was high at DIV 7 (22%), but signiﬁ  cantly lower 
(5%) in DIV 18  neurons (Roche et al., 2001), and hence comparable 
to the turnover-rate   determined in our hippocampal cultures at 
DIV 17. The developmental stabilization of NMDARs in the cell 
membrane reaching a turnover time constant of approximately 
10 h established here is in line with an NMDAR degradation proc-
ess also in the range of several hours, as shown for NR2A protein 
in DIV 8–9 cerebellar granule cells. Huh and Wenthold (1999) 
demonstrated that the half-life of total NR2A protein is 16 h and 
that of cell membrane-bound NR2A 20 h.
Previous studies indicated that NMDAR blockade of cultured cells 
increases the total number of NMDAR on neurons (Rao and Craig, 
1997; Liao et al., 1999; Crump et al., 2001). Chronic APV treatment 
of low-density hippocampal cultures increases several times the 
number of synaptic NR1 clusters per dendritic length (Crump et al., 
2001). We demonstrate that NMDAR blockade  differentially affects 
the regulation of NMDAR subtype   trafﬁ  cking. NR2A-containing 
receptors in the cell membrane are strongly up-regulated after 
blocking NMDARs and AMPARs, whereas NR2B-containing recep-
tors are not affected. Previous studies indicated that the regula-
tion of NMDAR expression is dependent on age and brain-region. 
0
60
100
80
120
20
40
%
ctr 8h APV
peak NMDA current
with ifen
**
NMDA
NMDA + ifenprodil
NMDA
NMDA + ifenprodil
control 8h APV
0
80
120
m
s
40
τw NMDA
*
200 ms
10 pA 20 pA
200 ms
ctr 8h APV
FIGURE 8 | APV treatment leads to a decrease in ifenprodil sensitivity 
and deactivation kinetics of synaptic NMDAR-mediated EPSCs. Synaptic 
EPSCs in CA1 pyramidal cells were evoked in hippocampal slices by 
stimulations of Schaffer collateral/commissural ﬁ  bers. Slices were incubated 
for 8 h in ACSF without (control) or with APV (8 h APV). NMDAR-mediated 
EPSCs were recorded at a holding potential of −70 mV in Mg2+-free ACSF . The 
ifenprodil (10 µM) sensitivity was signiﬁ  cantly smaller in slices incubated for 
8 h in APV than in control (ctr) slices (median ± IQR). There was also a 
signiﬁ  cant reduction in the τw of NMDAR-mediated EPSCs in cells of 
APV-treated slices, consistent with an increase in the synaptic contribution of 
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Quantitative electron microscopy studies indicated that in vivo 
cortical application of APV in adult rats alters the NR2A/NR2B 
ratio by increasing the number of synaptic NR2A-type receptors 
and decreasing the number of synaptic NR2B-type receptors (Aoki 
et al., 2003; Fujisawa and Aoki, 2003). However, opposite results were 
reported when neuronal activity was decreased by dark-rearing of 
animals during the critical period for ocular dominance, which pre-
vented the developmentally regulated increase of the NR2A/NR2B 
ratio in the visual cortex (Carmignoto and Vicini, 1992; Quinlan 
et al., 1999; Chen and Bear, 2007). One needs to keep in mind 
though that these experiments are difﬁ  cult to compare with ours 
since dark-rearing induced neuronal activity changes are most likely 
dissimilar to a complete blockade of NMDARs. Regional differences 
in the control of NR2A and NR2B protein might also explain why 
APV treatment caused an increase of NR2B protein only in cultures 
obtained from occipital cortex (Chen and Bear, 2007), but increased 
protein levels of both subtypes in hippocampal cultures (Rao and 
Craig, 1997). Furthermore, the duration of NMDAR blockade might 
be yet another factor accounting for the different results obtained in 
some of the studies. Thus, APV treatment of DIV 4–5 slice cultures 
for 60 h prevented the synaptic delivery of recombinant NR2A-but 
not NR2B-containing NMDAR (Barria and Malinow, 2002). Also 
most of the aforementioned studies investigated the inﬂ  uence 
on NMDAR expression by reducing cortical activity or blocking 
NMDARs for several days. In contrast, short NMDA blockade by 
in vivo cortical application of APV for 30–120 min in adult rats 
induced an increase of synaptic NR2A-containing NMDAR and a 
decrease of synaptic NR2B-containing NMDAR (Aoki et al., 2003; 
Fujisawa and Aoki, 2003).
Synaptic NMDAR levels are not only regulated by membrane 
insertion or internalization of NMDARs but also by lateral movement 
of extrasynaptic NMDARs into the synapse (Tovar and Westbrook, 
2002; Zhao et al., 2008). Our immunocytochemical experiments did 
not differentiate between extrasynaptic and synaptic NMDARs, but 
quantiﬁ  ed the increase in total NMDARs levels and in the inser-
tion of new receptors into the membrane. Hence, lateral move-
ment of NMDARs into the synapse cannot account for the changes 
observed in the immunocytochemical experiments. However, we 
cannot exclude that lateral diffusion contributed at least in part to 
the observed  electrophysiological changes (see below). Groc and col-
leagues showed that lateral movement is very different for NR2A and 
NR2B subunits. NR2A subunits reside fairly stably in the synapse, 
whereas NR2B subunits are highly mobile and move in and out of 
the synapse. This lateral movement of NR2B subunits is not activity-
dependent (Groc et al., 2006; Zhao et al., 2008), but is regulated in a 
subunit-dependent fashion by the extracellular matrix protein Reelin 
(Groc et al., 2007). Hence, we believe that activity- independent lateral 
movement of NMDARs and activity-dependent insertion of new 
receptors into the synapse are two independent mechanisms account-
ing for synaptic NMDAR metaplasticity. The immunocytochemical 
experiments of our study showed a change of total NR2A receptor 
content in the cell membrane upon NMDAR and AMPAR blockade. 
The physiologically relevant question as to whether these receptors 
are also integrated into the synapse was addressed by electrophysio-
logical measurements. An 8-h treatment with APV in culture and slice 
experiments clearly showed a signiﬁ  cant increase of the NMDA cur-
rent amplitude and faster deactivation kinetics. NMDAR-mediated 
current kinetics are modulated by many  parameters and mechanisms, 
including temperature (Hestrin et al., 1990; Cais et al., 2008), voltage 
(Konnerth et al., 1990; Clarke and Johnson, 2008), phosphorylation 
(Lu et al., 1999; Skeberdis et al., 2006), spermine (Rumbaugh et al., 
2000), the extent of glutamate spillover with activation of extrasynap-
tic NMDARs (Diamond, 2001; Lozovaya et al., 2004), and alternative 
splicing of exon 5 of the NR1 subunit transcript (Rumbaugh et al., 
2000). Some of these parameters (temperature and voltage) were 
constant in our experiments. It is possible that, e.g. phosphorylation/
dephosphorylation contributes to the changes in EPSC decay kinet-
ics. However, the concomitant decrease of ifenprodil sensitivity and 
increase of NVP sensitivity indicate that the synaptic N2RA/NR2B 
ratio is increased by 8 h of APV treatment. It is therefore likely that 
this ratio increase is the main cause of the changed EPSC kinet-
ics. These functional data are in line with the immunocytochemical 
results, showing that NMDAR activation increases the number of 
NR2A- but not NR2B-containing NMDAR in the cell membrane and 
increases the intensity and number of NR2A clusters. More NR2A-
type receptors in the membrane can result from increased insertion 
of new receptors or decreased internalization. Both the rate of inser-
tion (Dunah and Standaert, 2001; Lan et al., 2001a,b; Skeberdis et al., 
2001) and internalization (Vissel et al., 2001; Nong et al., 2003) can 
be regulated. Quantiﬁ  cation of new NR2A-type receptor insertion 
during NMDAR blockade indicated that the higher levels of NR2A-
containing receptors in the membrane might reﬂ  ect increased inser-
tion, with decreased internalization playing rather a minor role. In 
contrast, the increase during AMPAR blockade cannot be explained 
solely by more receptor insertion. The experiments with NVP and 
ifenprodil demonstrated that the activity of either NMDAR subtype 
was sufﬁ  cient to keep normal NMDAR levels. However, the inter-
pretation of data resulting from experiments with these antagonists 
is not straightforward, given their suboptimal subunit speciﬁ  city. 
Whilst 10 µM ifenprodil blocks most NR1/NR2B receptors (>80%) 
and nearly no NR1/NR2A receptors (Williams, 1993), 50 nM NVP 
blocks approximately 75% of NR1/NR2A receptors but also 25% 
of NR1/NR2B receptors (Berberich et al., 2005). In addition, both 
drugs are barely effective at blocking triheteromeric NR1/NR2A/
NR2B receptors (Paoletti and Neyton, 2007), which appear to con-
stitute a signiﬁ  cant proportion of the NMDARs (Sheng et al., 1994; 
Stephenson, 2001; Cull-Candy and Leszkiewicz, 2004). Thus, it is so 
far not possible to selectively block all NR2A- or NR2B-containing 
NMDAR receptors with pharmacological tools. It is of note that 
blocking activity with TTX, in contrast to NMDAR blockade, led 
only to a small, insigniﬁ  cant increase in the total number of cell 
membrane NR2A-type receptors. Groc et al. had previously also 
shown that chronic treatment of cultures (DIV 10–12) with TTX 
has no inﬂ  uence on the ifenprodil sensitivity of NMDAR-mediated 
EPSCs (Groc et al., 2007). Thus, receptor activation by spontaneously 
released glutamate is sufﬁ  cient to prevent an up-regulation of NR2A-
containing receptors, independent of AP generation. Moreover, a 
reduction of activity during AMPAR blockade and the consecutive 
decrease in NMDAR activation are unlikely to be the only expla-
nations for the pronounced effect on surface NR2A-type receptor 
levels by CNQX.
In summary, our study demonstrates that the number of 
synaptic NR2A- but not NR2B-type receptors is dependent on 
activation of ionotropic GluRs. Blockade for few hours leads Frontiers in Molecular Neuroscience  www.frontiersin.org  October 2009  | Volume 2  |  Article 19  |  13
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to an increase in NR2A-type receptors in the cell membrane, 
mainly by up-regulation of new receptor insertion. The recep-
tors are functionally integrated into the synapse and result in 
synaptic EPSCs with characteristics indicative of an increased 
NR2A/NR2B ratio. Thus, cellular activity affects the ratio of 
synaptic NR2A/NR2B-type receptors, enabling the neuron to 
react to reduced NMDAR and/or AMPAR activation, not only 
by an increased NMDA component, but also by faster kinetics 
of NMDA EPSCs.
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